Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wendling

Showing results (351-360 of 496) with videos related to

Pageof 50
Sort By:
Rheumatology (Oxford, England)|April 8, 2016
Etanercept improves endothelial function via pleiotropic effects in rat adjuvant-induced arthritisPerle Totoson, Katy Maguin-Gaté, Anne Prigent-Tessier, et al.
Clinical Rheumatology|August 24, 2017
Serum adipokines, adipose tissue measurements and metabolic parameters in patients with advanced radiographic knee osteoarthritisEric Toussirot, Fabrice Michel, Matthieu Béreau, et al.
Annals of the Rheumatic Diseases|July 10, 2025
When borders impact science: what is the future of European rheumatology research?Frank Verhoeven, Athan Baillet, Celine Demougeot, et al.
Arthritis Research & Therapy|July 3, 2009
Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activityEric Toussirot, Philippe Saas, Marina Deschamps, et al.
The Journal of Rheumatology|December 17, 2011
Scleritis: a paradoxical effect of etanercept? Etanercept-associated inflammatory eye diseaseCécile Gaujoux-Viala, Cecilia Giampietro, Thomas Gaujoux, et al.
Rheumatology (Oxford, England)|March 24, 2023
Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospitalSophie Hecquet, Alice Combier, Alexia Steelandt, et al.
Joint Bone Spine|July 26, 2005
Infliximab continuation rates in patients with rheumatoid arthritis in everyday practiceDaniel Wendling, Guewen-Edouard Materne, Fabrice Michel, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort studyAlain Saraux, Jacques Benichou, Loic Guillevin, et al.
Joint Bone Spine|September 8, 2020
Serum calprotectin is increased in early axial spondyloarthritis with sacroiliitis and objective signs of inflammation: Results from the DESIR cohortXavier Romand, Marie-Hélène Paclet, Anaïs Courtier, et al.
European Cytokine Network|March 14, 2007
Effects of tumor necrosis factor antagonist treatment on hepatitis C-related immunological abnormalitiesChristelle Vauloup, Roman Krzysiek, Liliane Greangeot-Keros, et al.
Pageof 50

Showing results (351-360 of 496) with videos related to

Sort By:
Pageof 50
Rheumatology (Oxford, England)|April 8, 2016
Etanercept improves endothelial function via pleiotropic effects in rat adjuvant-induced arthritisPerle Totoson, Katy Maguin-Gaté, Anne Prigent-Tessier, et al.
Clinical Rheumatology|August 24, 2017
Serum adipokines, adipose tissue measurements and metabolic parameters in patients with advanced radiographic knee osteoarthritisEric Toussirot, Fabrice Michel, Matthieu Béreau, et al.
Annals of the Rheumatic Diseases|July 10, 2025
When borders impact science: what is the future of European rheumatology research?Frank Verhoeven, Athan Baillet, Celine Demougeot, et al.
Arthritis Research & Therapy|July 3, 2009
Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activityEric Toussirot, Philippe Saas, Marina Deschamps, et al.
The Journal of Rheumatology|December 17, 2011
Scleritis: a paradoxical effect of etanercept? Etanercept-associated inflammatory eye diseaseCécile Gaujoux-Viala, Cecilia Giampietro, Thomas Gaujoux, et al.
Rheumatology (Oxford, England)|March 24, 2023
Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospitalSophie Hecquet, Alice Combier, Alexia Steelandt, et al.
Joint Bone Spine|July 26, 2005
Infliximab continuation rates in patients with rheumatoid arthritis in everyday practiceDaniel Wendling, Guewen-Edouard Materne, Fabrice Michel, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort studyAlain Saraux, Jacques Benichou, Loic Guillevin, et al.
Joint Bone Spine|September 8, 2020
Serum calprotectin is increased in early axial spondyloarthritis with sacroiliitis and objective signs of inflammation: Results from the DESIR cohortXavier Romand, Marie-Hélène Paclet, Anaïs Courtier, et al.
European Cytokine Network|March 14, 2007
Effects of tumor necrosis factor antagonist treatment on hepatitis C-related immunological abnormalitiesChristelle Vauloup, Roman Krzysiek, Liliane Greangeot-Keros, et al.
Pageof 50